nerve-cell-0106 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Minerva Neurosciences’ roluperidone fails in Phase III study

The trial is intended for the treatment of negative symptoms in schizophrenia. Credit: Colin Behrens from Pixabay.